š—”š—²š˜„š˜€ š—¦š˜‚š—ŗš—ŗš—®š—æš˜†
• Lupin Limited has secured tentative approval from the US FDA for its generic version of Uptravi for Injection, 1800 mcg/vial.
• The approval will allow the company to market the product, which is used to treat pulmonary arterial hypertension, in the US.
• Lupin also received a positive inspection report from the US health regulator for its manufacturing facility in Madhya Pradesh.